Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $21.42B. Across the group, the median move over the past trading day is +1.97%. Price change over the past year runs from +13.0% to +48.7% across the middle 80 percent of the group, with a median of +21.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| ONC | BeOne Medicines AG | $376.37 | +15.49% | +21.01% | +21.95% |
| BNTX | BioNTech SE | $114.05 | +25.21% | +17.95% | +8.55% |
| GMAB | Genmab A/S | $34.36 | +19.31% | +7.98% | +41.34% |
| 0J9P.L | Incyte Corporation | $130.13 | +1.97% | +30.41% | +53.55% |
| 0M2N.L | Orion Oyj | 80.50 EUR | +12.46% | +29.29% | +19.68% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.